In HCC, elevated PKM2 expression in tumor tissues has been correlated with aggressive clinicopathological features, including larger tumor size, higher tumor-node-metastasis (TNM) stage, and poorer overall survival [11,29]. Here, PKM is linked to hepatocellular carcinoma.